专题：Cervical Cancer and HPV Research

This cluster of papers focuses on the epidemiology, burden, and prevention of cervical cancer associated with Human Papillomavirus (HPV) infection. It covers topics such as HPV vaccination, viral oncogenes, genotype distribution, cytology screening, and the global burden of HPV-related cancers.
最新文献
Cervical cancer mortality trends following HPV vaccination in England, 2001–24: an analysis of population-based mortality data

article Full Text OpenAlex

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of human papillomavirus (HPV) DNA genotyping. Web Annex A. Evidence summaries

book Full Text OpenAlex

Endometrial Cancer

review Full Text OpenAlex

Cervical Cancer Epidemiology: Global Incidence, Mortality, Survival, Risk Factors, and Equity in HPV Screening and Vaccination

review Full Text OpenAlex

Human papillomavirus and vaccine knowledge, willingness, and uptake among university students: a systematic review and meta-analysis

review Full Text OpenAlex

Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology

article Full Text OpenAlex

Noninferiority of One HPV Vaccine Dose to Two Doses

article Full Text OpenAlex

Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline

article Full Text OpenAlex

Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination

review Full Text OpenAlex

Cervical cancer burden in India: A descriptive epidemiological study and policy insights

article Full Text OpenAlex

近5年高被引文献
Cancer statistics, 2023

article Full Text OpenAlex 16294 FWCI2012.1811

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative

article Full Text OpenAlex 1609 FWCI228.9019

HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

review Full Text OpenAlex 987 FWCI46.7296

Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis

article Full Text OpenAlex 555 FWCI78.113

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

article Full Text OpenAlex 520 FWCI101.5307

Cervical Cancer Screening

review Full Text OpenAlex 499 FWCI19.9556

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

article Full Text OpenAlex 477 FWCI149.9208

Cervical cancer therapies: Current challenges and future perspectives

review Full Text OpenAlex 476 FWCI15.2444

Survival with Cemiplimab in Recurrent Cervical Cancer

article Full Text OpenAlex 471 FWCI96.78

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

article Full Text OpenAlex 418 FWCI232.7947